Louie Ngar Yee

SEC Form 4 insider trading activity

Louie Ngar Yee has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 23, 2025.

On the most recent filing, Louie Ngar Yee is listed as Director at MAIA Biotechnology, Inc. Inside the rolling window, Louie Ngar Yee reported 1 open-market purchase totaling $100K in MAIA and no open-market sales.

Companies traded

Other insiders at MAIA

Insider Buying

$100K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MAIA
Louie Ngar Yee
Purchase$100KDec 23SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Louie Ngar Yee made?

Louie Ngar Yee has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.

Which companies does Louie Ngar Yee trade?

Louie Ngar Yee has filed SEC Form 4 disclosures for 1 company, including MAIA.

When was Louie Ngar Yee's most recent SEC Form 4 filing?

Louie Ngar Yee's most recent SEC Form 4 filing on Tracefour is dated Dec 23, 2025.

What is Louie Ngar Yee's total buy and sell value in the current window?

Inside the rolling retention window, Louie Ngar Yee bought $100K and sold $0 based on SEC Form 4 filings.

What was Louie Ngar Yee's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 81,699 MAIA shares on 2025-12-22, worth $100K, per SEC Form 4 filings.